Mancikova, V; Matias-Guiu, X; Puig-Domingo, M; Capel, I; Rosa Bella, M; Lerma, E; Castella, Eva; Lluis Reverter, J; Angel Peinado, M; Jorda, M; Robledo, M; Buj, R; Castelblanco, E; Inglada-Perez, L; Diez, A; de Cubas, AA; Curras-Freixes, M; Xavier Maravall, F; Mauricio, D; ,
Differentiated thyroid carcinoma (DTC) has a favorable prognosis, but it is important to identify those patients who have a high risk of progressive disease and DTC-related death at the time of diagnosis. Analyzing genetic and epigenetic alterations in thyroid cancer may play a role in tumor diagnosis, prognostic and therapeutic strategies.
